Page 17 - Genscript Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has triggered the worldwide coronavirus disease 2019 (COVID-19) pandemic. Serological assays for the detection of SARS-CoV-2 infections are important to understand the immune response in patients and to obtain epidemiological data about the number of infected people, especially to identify asymptomatic persons not aware of a past infection. We recombinantly produced SARS-CoV-2 nucleocapsid (N)-protein in Escherichia coli. We used the purified protein to develop an indirect enzyme-linked immunosorbent assay (ELISA) for the detecti...

Revenue of the Group for the year ended December 31, 2021 was approximately US$511.1 million, representing an increase of 30.8% as compared with appro

Sales in the global Gene Editing Tools Market are slated to top US$ 481.3 Mn in 2022. Expanding at a healthy 18.8% CAGR, the market size is projected to total US$ 1.6 Bn by 2029.

Johnson & Johnson (JNJ) is in negotiations with two Chinese biotech companies for partnerships, The Financial Times reported Sunday, citing a senior executive of the U.S. pharma giant

The Emerging Markets Internet Ecommerce ETF (EMQQ) could be affected by some index alterations in Hong Kong, and that might be a positive for investors.